Irene Virgolini

17PUBLICATIONS
66CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Professional ethicsNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jun 06, 2026
Real-world outcomes of [177Lu]Lu-PSMA-I&T in [18F]FDG-positive metastatic castration-resistant prostate cancer: factors related to response and survival.

|Feb 14, 2026
Peptide receptor radionuclide therapy in neuroendocrine tumours: advances, combination strategies, and future directions.

Irene J Virgolini, Gianpaolo Di Santo, Giulia Santo

|Jan 28, 2026
Paving the Way for CCK2R-Targeted Peptide Receptor Radionuclide Therapy with [177Lu]Lu-DOTA-MGS5 in Patients with Small Cell Lung Cancer.

Taraneh Sadat Zavvar, Giulia Santo, Leonhard Gruber

|Oct 21, 2025
Peptide receptor radionuclide therapy alone or in combination with temozolomide plus/minus capecitabine in [18F]FDG-positive metastatic neuroendocrine tumors.

Gianpaolo di Santo, Giulia Santo, Lukas Wirth

|Jun 30, 2025
Calcitonin and procalcitonin measurement after cholecystokinin-2/gastrin receptor agonist stimulation in patients with advanced medullary thyroid cancer: results from the GRAN-T-MTC study.

Małgorzata Trofimiuk-Müldner, Katica Bajuk Studen, Paola Anna Erba

|May 30, 2025
Correction to: Guiding principles on the education and practice of theranostics.

Thomas N B Pascual, Diana Paez, Andrei Iagaru

Pageof 3

Frequent Collaborators

5 joint publications

Giulia Santo

3 joint publications

Clemens Decristoforo

3 joint publications

Murat Tuncel

3 joint publications

Andrew M Scott